国药科技股份：余秉明获选举为独立非执行董事

Core Viewpoint - China National Pharmaceutical Technology Corporation (国药科技股份) announced changes in its board of directors following the annual general meeting, including the resignation and appointment of several independent non-executive directors [1] Group 1: Board Changes - Dr. Cheng Yanjie has retired as a non-executive director of the company after the annual general meeting [1] - Mr. Diao Zhiqiang and Mr. Yu Bingming were elected as independent non-executive directors by the shareholders during the annual general meeting [1] - Mr. Xu Dong'an has resigned as an independent non-executive director due to other business commitments, effective from December 19, 2025 [1] Group 2: Committee Composition Changes - Following the resignation of Mr. Xu, several changes to the board committees will take effect from December 19, 2025: - Mr. Xu has stepped down as the chairman of the nomination committee and as a member of the audit committee, remuneration committee, and nomination committee [1] - Ms. Guo Shuyi has been appointed as a member of the remuneration committee and nomination committee [1] - Mr. Liu Fei has been appointed as the chairman and a member of the nomination committee [1] - Mr. Diao has been appointed as a member of the audit committee, remuneration committee, and nomination committee [1] - Mr. Yu has been appointed as a member of the audit committee and remuneration committee [1]